LAV BIOSCIENCES FUND V, L.P. reported 6 transactions at ADARX PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
+8.91M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.67M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+513.07K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+153.87K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+307.74K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+307.74K
Price / share
—
Trade value
—
% of position
Net shares
+11.86M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2026 | C · Conversion | +8.91M | — | — | New position | 0.00 | 8.91M |
| Common Stock Direct | 9/28/2026 | C · Conversion | +1.67M | — | — | 18.7% | 8.91M | 10.58M |
| Common Stock Direct | 9/28/2026 | C · Conversion | +513.07K | — | — | 4.9% | 10.58M | 11.09M |
| Common Stock Direct | 9/28/2026 | C · Conversion | +153.87K | — | — | 1.4% | 11.09M | 11.24M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +307.74K | — | — | New position | 0.00 | 307.74K |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +307.74K | — | — | New position | 0.00 | 307.74K |
| Total | +11.86M | $0.00 | ||||||
Series A Preferred Stock
Common Stock
8.91M shares
Shares
−10.44M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
1.67M shares
Shares
−1.95M
Strike price
Held after
0.00
Exercisable
—
Series B-1 Preferred Stock
Common Stock
513.07K shares
Shares
−601.16K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
153.87K shares
Shares
−180.29K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
307.74K shares
Shares
−360.58K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
307.74K shares
Shares
−360.58K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock8.91M shares | 9/28/2026 | C · Conversion | −10.44M | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock1.67M shares | 9/28/2026 | C · Conversion | −1.95M | — | 0.00 | |
| Series B-1 Preferred Stock Direct | Common Stock513.07K shares | 9/28/2026 | C · Conversion | −601.16K | — | 0.00 | |
| Series C Preferred Stock Direct | Common Stock153.87K shares | 9/28/2026 | C · Conversion | −180.29K | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock307.74K shares | 9/28/2026 | C · Conversion | −360.58K | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock307.74K shares | 9/28/2026 | C · Conversion | −360.58K | — | 0.00 |